Nephrogenic syndrome of inappropriate antidiuresis

Area of Science:

• Endocrinology
• Genetics
• Nephrology

Background:

• Mutations in the vasopressin V2 receptor gene lead to two distinct human tubular disorders.
• X-linked congenital nephrogenic diabetes insipidus results from V2 receptor loss-of-function.
• Nephrogenic syndrome of inappropriate antidiuresis stems from constitutive V2 receptor activation.

Purpose of the Study:

• To investigate the genetic basis and clinical manifestations of V2 receptor-related tubular disorders.
• To explore the pathophysiology and phenotypic variability in nephrogenic syndrome of inappropriate antidiuresis.
• To review current and potential treatment strategies for these conditions.

Main Methods:

• Genetic analysis of the vasopressin V2 receptor gene in affected individuals.
• Clinical case review of patients diagnosed with nephrogenic syndrome of inappropriate antidiuresis.
• Literature review of V2 receptor mutations and associated phenotypes.

Main Results:

• Two missense mutations in the V2 receptor gene have been identified in patients.
• Nephrogenic syndrome of inappropriate antidiuresis can present from infancy to adulthood, with variable asymptomatic periods.
• Symptomatic patients exhibit hyponatremia and high urine osmolality despite low plasma arginine vasopressin levels.

Conclusions:

• Vasopressin V2 receptor gene mutations are central to these tubular disorders.
• The pathophysiology underlying phenotypic variability in patients with identical mutations requires further investigation.
• Current management focuses on fluid restriction, with urea as a potential therapeutic option.